We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

116 hedge funds and large institutions have $994M invested in Pacira BioSciences in 2013 Q2 according to their latest regulatory filings, with 116 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more call options, than puts

Call options by funds: $3.08M | Put options by funds: $2.44M

Holders
116
Holders Change
+116
Holders Change %
–
% of All Funds
3.79%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
116
Increased
–
Reduced
–
Closed
–
Calls
$3.08M
Puts
$2.44M
Net Calls
+$648K
Net Calls Change
+$648K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$173M +$173M +5,964,703 New
GGHC
2
Gilder Gagnon Howe & Co
New York
$119M +$119M +4,118,765 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$78.2M +$78M +2,695,528 New
Jennison Associates
4
Jennison Associates
New York
$75.4M +$75.3M +2,601,374 New
VAM
5
Visium Asset Management
New York
$58.3M +$58.1M +2,010,000 New
AllianceBernstein
6
AllianceBernstein
Tennessee
$42.2M +$42.1M +1,453,731 New
BFA
7
BlackRock Fund Advisors
California
$30.8M +$30.7M +1,061,198 New
Franklin Resources
8
Franklin Resources
California
$27.1M +$27M +933,720 New
State Street
9
State Street
Massachusetts
$25.2M +$25.2M +869,841 New
MAM
10
MPM Asset Management
Massachusetts
$23.9M +$23.8M +824,255 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$22.2M +$22.2M +766,620 New
WSA
12
Wall Street Associates
California
$22.1M +$22M +761,709 New
Millennium Management
13
Millennium Management
New York
$16.8M +$16.8M +579,390 New
TCM
14
Tamarack Capital Management
California
$15.9M +$15.9M +548,900 New
AWMDMG
15
Austin W. Marxe & David M. Greenhouse
New York
$14.5M +$14.5M +499,829 New
O
16
OrbiMed
New York
$14.4M +$14.4M +498,000 New
RIM
17
RS Investment Management
California
$14.2M +$14.2M +491,216 New
Calamos Advisors
18
Calamos Advisors
Illinois
$14.1M +$14.1M +486,670 New
SIMG
19
Stephens Investment Management Group
Texas
$13.4M +$13.3M +460,697 New
PWPCM
20
Perella Weinberg Partners Capital Management
New York
$12.6M +$12.5M +433,202 New
PC
21
Polar Capital
United Kingdom
$11M +$11M +378,718 New
BIT
22
BlackRock Institutional Trust
California
$11M +$10.9M +377,641 New
Deutsche Bank
23
Deutsche Bank
Germany
$10.4M +$10.4M +358,345 New
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$9.05M +$9.03M +312,008 New
Wellington Management Group
25
Wellington Management Group
Massachusetts
$9.04M +$9.02M +311,700 New
1
2 3 4 5

PCRX Hedge Fund Activity: Q2 2013 in Review

116 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q2 2013, worth a combined $994M.

Buyers outnumbered sellers: 116 funds opened new PCRX positions and 0 closed out — a net gain of 116 holders — while 0 added to existing stakes and 0 trimmed.

  • 116 institutional investors held Pacira BioSciences (PCRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $994M of Pacira BioSciences stock for Q2 2013.
  • 116 funds opened new Pacira BioSciences positions in Q2 2013 and 0 closed out, a net change of +116 holders.

Based on aggregated 13F filings for Q2 2013.